clinical studies
| 4 min read
By explicitly specifying treatment effects and intercurrent events, estimands help sponsors, clinicians, and regulators work from a shared understanding.
| 2 min read
The milestone marks meaningful progress toward developing new therapeutic options for Alport syndrome, with first-patient dosing expected in early 2026.
| 3 min read
New study finds limited value from nearly one-third of clinical trial procedures and associated data, highlighting opportunity for more patient-centric trial design
| 2 min read
A $500k award will support a two-phase study enrolling pregnant women to advance understanding of placental dysfunction.
| 2 min read
The ABX-01 is a broad-spectrum antimicrobial specifically selected to combat clinically prevalent and multidrug-resistant bacterial strains.
| 3 min read
Epilepsy onset and seizure severity are linked to variants in the SCN2A gene, potentially leading to improved diagnostics and treatments.
Page 1 of 1 - 6 Total Items
